A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancer

BACKGROUND: Bone-targeting agents (BTAs), such as bisphosphonates and denosumab, have demonstrated no discernable effects on tumour response or disease free/overall survival in patients with bone metastases from breast cancer. Doxycycline is both osteotropic and has anti-cancer effects. When combine...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Bone Oncol
Main Authors: Addison, C.L., Simos, D., Wang, Z., Pond, G., Smith, S., Robertson, S., Mazzarello, S., Singh, G., Vandermeer, L., Fernandes, R., Iyengar, A., Verma, S., Clemons, M.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2016
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5154696/
https://ncbi.nlm.nih.gov/pubmed/28008379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2016.06.003
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki